Long G L, Lu D, Xie R L, Kalafatis M
Department of Biochemistry, University of Vermont College of Medicine, Burlington, Vermont 05405-0068, USA.
J Biol Chem. 1998 May 8;273(19):11521-6. doi: 10.1074/jbc.273.19.11521.
Human factor Xa specifically cleaves the anticoagulant protein S within the thrombin-sensitive domain. Amino-terminal amino acid sequencing of the heavy chain cleavage product indicates cleavage of protein S by factor Xa at Arg60, a site that is distinct from those utilized by alpha-thrombin. Cleavage by factor Xa is unaffected by the presence of hirudin and is completely blocked by tick-anticoagulant-peptide and D-Glu-Gly-Arg-chloromethyl ketone, the latter two being specific inhibitors of factor Xa. The cleavage requires the presence of phospholipid and Ca2+, and is markedly inhibited by the presence of factor Va. Factor Xa-cleaved protein S no longer possesses its activated protein C-dependent or -independent anticoagulant activity, as measured in a factor VIII-based activated partial thromboplastin time clot assay. The apparent binding constant for protein S binding to phospholipid (Kd approximately 4 nM +/- 1.0) is unaffected by factor Xa or thrombin cleavage, suggesting that the loss of anticoagulant activity resulting from cleavage is not primarily due to the loss of membrane binding ability. Cleavage and inactivation of protein S by factor Xa may be an additional way in which factor Xa exerts its procoagulant effect, after the initial stages of clot formation.
人凝血因子Xa特异性地在凝血酶敏感域内切割抗凝蛋白S。重链切割产物的氨基末端氨基酸测序表明,凝血因子Xa在Arg60处切割蛋白S,该位点不同于α-凝血酶所作用的位点。凝血因子Xa的切割不受水蛭素存在的影响,但完全被蜱抗凝肽和D-谷氨酸-甘氨酸-精氨酸氯甲基酮阻断,后两者是凝血因子Xa的特异性抑制剂。这种切割需要磷脂和Ca2+的存在,并且会被因子Va的存在显著抑制。在基于因子VIII的活化部分凝血活酶时间凝血试验中检测发现,凝血因子Xa切割后的蛋白S不再具有其依赖活化蛋白C或不依赖活化蛋白C的抗凝活性。蛋白S与磷脂结合的表观结合常数(Kd约为4 nM±1.0)不受凝血因子Xa或凝血酶切割的影响,这表明切割导致的抗凝活性丧失并非主要由于膜结合能力的丧失。在凝血形成的初始阶段之后,凝血因子Xa对蛋白S的切割和失活可能是凝血因子Xa发挥促凝作用的另一种方式。